# Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Source: https://onco.cc/trials/nct02234297/  
OnCo record `nct02234297` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.

## Summary

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery is a phase 1 interventional study registered as NCT02234297 by Blaze Bioscience Inc., with 17 participants enrolled, started 2014-10. Conditions recorded: Glioma. Interventions recorded: BLZ-100.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02234297
- Phase: 1
- Setting: A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery
- Sponsor: Blaze Bioscience Inc.
- Enrolled: 17

## Sources

- ClinicalTrials.gov NCT02234297: https://clinicaltrials.gov/study/NCT02234297

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/)
- drugs: [Tozuleristide](https://onco.cc/drugs/blz-100/)
- companies: [Blaze Bioscience](https://onco.cc/companies/blaze-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct02234297.json